← IMUX
IMUX— IMMUNIC, INC.
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Research and development | $82.0M+2.4% | $80.0M-3.8% | $83.2M+16.8% | $71.3M+16.6% | $61.1M+58.2% | $38.6M+71.6% | $22.5M+134.6% | $9.6M |
| General and administrative | $21.2M+18.0% | $18.0M+12.5% | $16.0M+4.9% | $15.3M+14.8% | $13.3M+28.7% | $10.3M-28.8% | $14.5M+504.5% | $2.4M |
| Total operating expenses | $103.2M+5.3% | $98.1M-1.2% | $99.2M-17.0% | $119.5M+30.4% | $91.7M+87.2% | $49.0M+32.2% | $37.0M+208.7% | $12.0M |
| Loss from operations | -$103.2M-5.3% | -$98.1M+1.2% | -$99.2M+17.0% | -$119.5M-30.4% | -$91.7M-87.2% | -$49.0M-32.2% | -$37.0M-208.7% | -$12.0M |
| Interest income | $1.0M-69.3% | $3.4M+10.2% | $3.1M+195.4% | $1.0M+1477.3% | $66K+13.8% | $58K-45.8% | $107K | — |
| Change in fair value of the tranche rights | $0+100.0% | -$4.8M | $0 | — | — | — | — | — |
| Other income (expense), net | $5.0M+578.2% | -$1.0M-141.4% | $2.5M+229.4% | -$2.0M-45.6% | -$1.3M-127.5% | $4.9M+145.8% | $2.0M+336.8% | $456K |
| Total other income (expense), net | $6.1M+346.7% | -$2.5M-143.8% | $5.6M+710.6% | -$919K+28.2% | -$1.3M-125.8% | $5.0M+136.0% | $2.1M+361.3% | $455K |
| Net loss | -$97.2M+3.3% | -$100.5M-7.4% | -$93.6M+22.3% | -$120.4M-29.5% | -$92.9M-111.2% | -$44.0M-26.0% | -$34.9M-202.7% | -$11.5M |
| Net loss per share, basic (in usd per share) | -$620+38.0% | -$1K+52.6% | -$2K+44.2% | -$4K+3.8% | -$4K-39.9% | -$3K | — | — |
| Net loss per share, diluted (in usd per share) | -$620+38.0% | -$1K+52.6% | -$2K+44.2% | -$4K+3.8% | -$4K-39.9% | -$3K | — | — |
| Weighted-average common shares outstanding, basic (in shares) | $155.69B+55.4% | $100.17B+126.0% | $44.32B+39.3% | $31.82B+34.5% | $23.65B+51.0% | $15.66B | — | — |
| Weighted-average common shares outstanding, diluted (in shares) | $155.69B+55.4% | $100.17B+126.0% | $44.32B+39.3% | $31.82B+34.5% | $23.65B+51.0% | $15.66B | — | — |
Source: SEC EDGAR XBRL. % change vs prior period shown where available.
Source: SEC EDGAR 10-K and 10-Q filings. Up to 10 years annual / 16 quarters shown.